Skip to content

EMOTIon and COgNitive function after atrial fibrillation catheter ablation vs. medical therapy; randomized clinical trial (EMOTICON trial)

EMOTIon and COgNitive function after atrial fibrillation catheter ablation vs. medical therapy; randomized clinical trial (EMOTICON trial)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008136
Enrollment
320
Registered
2023-01-17
Start date
2021-10-07
Completion date
Unknown
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : By comparing and evaluating the atrial fibrillation ceramic resection group and the drug treatment group, cognitive function and depression psychological test are conducted six mon

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Left atrium size of atrial fibrillation patients < 55 mm 2. Atrial fibrillation with antiarrhythmic resistance 3. Patients with anticoagulant therapy (admission of anti-coagulation drugs to prevent cerebral infarction)

Exclusion criteria

Exclusion criteria: 1. Atrial fibrillation accompanied by structural heart disease affected by severe cardiac deformity or hemodynamic effects 2. Patients receiving treatment for cognitive dysfunction, emotional disorder, and anxiety disorder 3. Patients with active internal bleeding 4. Anticoagulant maladjustment 5. Significant comorbidities of symptoms 6. Patients expected to have a survival period of less than one year. 7. Patients with drug or alcoholism 8. Among the subjects, those who cannot read the consent form (literacy, foreigners, etc.) 9. Patients who are deemed unfit to participate in clinical research based on the judgment of other researchers.

Design outcomes

Primary

MeasureTime frame
rate of hospitalization;Major cardiovascular seizure rates;mortality;recurrence rate of atrial fibrillation

Secondary

MeasureTime frame
Major complication associated with the procedure : complication of hemorrhagic and embolic

Countries

Korea, Republic of

Contacts

Public ContactTaemin Kim

Yonsei University Health System, Severance Hospital

does34@yuhs.ac+82-2-2228-0923

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026